date:Jan 15, 2019
tion of WADA and USADA banned lists and modifications. This leaves stakeholders like Kalman concerned about whether a program is or isnt following the spirit or letter of the WADA rules.
One glaring example is the category of myostatin inhibitors. Myostatin is a signaling protein that can trigger increased muscle protein breakdown, the opposite of what most athletes want. Inhibiting mysostatin, then, creates a more favorable muscle building state.
WADA has recently prohibited Myostatin inhibit